Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sanjay R. Chemburkar
ABT-263 and Rapamycin Act Cooperatively to Kill Lymphoma Cells in Vitro and in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
ABT-263 Induces G1/G0-Phase Arrest, Apoptosis and Autophagy in Human Esophageal Cancer Cells in Vitro
Acta Pharmacologica Sinica
Medicine
Pharmacology
Flavopiridol Enhances ABT-199 Sensitivity in Unfavourable-Risk Multiple Myeloma Cells in Vitro and in Vivo
British Journal of Cancer
Cancer Research
Oncology
Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199
PLoS ONE
Multidisciplinary
Norcantharidin Enhances ABT-263-mediated Anticancer Activity in Neuroblastoma Cells by Upregulation of Noxa
Oncology Reports
Medicine
Cancer Research
Oncology
Carfilzomib Interacts Synergistically With Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells in Vitro and in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Enhanced Antitumor Activity of 3-Bromopyruvate in Combination With Rapamycin in Vivo and in Vitro
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Pitavastatin Suppressed Liver Cancer Cells in Vitro and in Vivo
OncoTargets and Therapy
Oncology
Pharmacology
Burkitt's Lymphoma: Differential Killing of Epstein-Barr Virus (EBV) (+) and EBV(-) Burkitt Lymphoma Cells in Vitro and Dose-Dependent Lytic Induction by Bortezomib in Vivo
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells in Vitro and Controls Tumor Expansion in Vivo via Low-Affinity Activating Fc Receptors
Cancer Research
Cancer Research
Oncology
